Herpes infections soar globally as new study reveals massive disease burden

Unveiling a global crisis: groundbreaking research highlights the immense impact of HSV infections on health, urging a shift...

Sexual health symptoms associated with lower adherence to breast cancer therapy in Black women

Among patients with early-stage breast cancer treated with adjuvant endocrine therapy (AET), symptoms related to sexual health were...

The impact of extreme weather events on HIV prevention and care

Extreme weather events linked to climate change exacerbate health inequities for people living with HIV, impacting prevention, care,...

GP comments on gonorrhea as antibiotic resistant cases rise

Sexual health expert and GP at LloydsPharmacy Online Doctor, Dr Bhavini Shah (she/her) explains who is most at risk...

Ethical hurdles of integrating telemedicine in sexual medicine

The perspective article titled"Ethical perspective on telemedicine usage in sexual medicine: A friend or a foe?", was published...

Trump restores Title X funding for two anti-abortion states — while wiping it out elsewhere

The Trump administration quietly restored federal family planning money to Tennessee and Oklahoma, despite court rulings that the...

Exploring sexual health challenges in women with pelvic floor disorders

Many women experience problems due to a weakened or damaged pelvic floor. These ailments are most common in...

Complexities and emotional challenges of STI disclosure to sexual partners

A review of research to-date reveals the complex nature of revealing a diagnosis of a sexually transmitted infection...

Nonheterosexual women report better sexual function during menopause transition

A woman's sex drive may diminish with age - partially because of problems with genitourinary symptoms during the...

PrEP, a key HIV prevention tool, isn’t reaching Black women

Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for...

Mount Sinai leads the way with first HYDROS Robotic System procedure in New York City

The Mount Sinai Hospital has performed New York City's first procedure using the HYDROS™ Robotic System, a cutting-edge...

Societies need to give clearer, explicit support for breastfeeding in public, researchers say

International law supports women's right to breastfeed in the public. However, women report having been subjected to negative...

New survey highlights gaps in menopause knowledge and management

The Kinsey Institute at Indiana University, in partnership with leading sexual wellbeing company the Lovehoney Group and its...

Study finds lifelong orgasm gap influenced by age, gender, and sexual orientation

Scientists at Indiana University, USA, have explored age-related disparities in orgasm rates from sexual intercourse by gender and...

Body image and overall health found important to the sexual health of older gay men, according to new studies

According to a National Poll on Healthy Aging, 93% of people in the U.S. between 50-80 years old report experiencing...

Only 43% of parents use patient portal benefits for their children, poll finds

For many busy families, online access to a child's health provider for medical advice, health records or prescription...

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to...

Urologist weighs in on why men avoid doctor visits

Data has consistently shown that men are reluctant to seek medical care despite the fact they generally face higher mortality...

CDC firings undermine public health work far beyond Washington

The Trump administration’s sudden firing of Centers for Disease Control and Prevention employees gutted training programs across the...

New STI impacts 1 in 3 women: Landmark study reveals men are the missing link

A landmark study reveals that bacterial vaginosis (BV), a condition affecting nearly a third of women worldwide and...

ChatGPT could be an effective tool to help reduce vaccine hesitancy

New research being presented at this year's ESCMID Global Congress (formerly ECCMID) in Barcelona, Spain (27-30 April) suggests that the free-to-use, widely accessible ChatGPT could be an effective tool to help reduce vaccine hesitancy among the general public, as well as providing helpful advice on sexually transmitted infections (STIs) in conjunction with sexual health clinics, by improving knowledge and access to care.

Our findings showed that ChatGPT displayed a remarkable ability to accurately respond to a wide breadth of commonly asked questions, encompassing topics such as misconceptions around mRNA vaccination and the importance of testing for STIs. In the majority of instances, ChatGPT performed at the level of advice provided by professional organizations and guidelines."

Dr Matthew Koh,lead author from the National University Health System (NUHS) in Singapore

Since its unveiling in November 2022, millions of people have used AI (artificial intelligence) chatbots like ChatGPT for everything from making music to answering trivia to helping with homework. But ChatGPT has been mired in issues around its accuracy.

Vaccines have stopped epidemics and almost eradicated deadly diseases in the past such as polio, but vaccine hesitancy, directly linked to misinformation – false, inaccurate information promoted as factual – is on the rise, resulting in lower vaccine uptake. Since the public debut of ChatGPT, individuals with mistrust of health professionals may be using the technology to address their concerns.

Similarly, for individuals trying to access information on sexual health, or those worried about the stigma and embarrassment of attending a clinic, or with limited access to healthcare, could find using ChatGPT is a good way to get answers about STIs.

To find out more, researchers from the NUHS in Singapore tested ChatGPT to see whether it could successfully provide answers to common questions about vaccination and STIs.

A team of physicians who run infectious disease clinics asked ChatGPT to answer 15 commonly asked questions on vaccine hesitancy, including questions on doubts about the efficacy of vaccines, concerns about adverse effects, and cultural concerns relating to vaccines (see table in notes to editors).

They also asked ChatGPT 17 common questions on STIs based on general risk factors, access to care and diagnosis, and management and post-exposure prophylaxis (see table in notes to editors).

The AI-generated responses on vaccine hesitancy were then assessed by two independent infectious disease experts against recommendations from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), and the chatbot answers on STIs were assessed against the 2021 US CDC STI Treatment Guidelines. All responses were evaluated for their completeness, quality, and accuracy.

Factual responses to vaccine hesitancy concerns

The researchers found that overall ChatGPT's output provided factual responses and reassurance to vaccine hesitancy concerns.

For example, ChatGPT accurately highlighted the indication for measles vaccination in low incidence settings, and discussed the potential benefits of male human papillomavirus (HPV) vaccination. However, the AI chatbot failed to acknowledge the suggested ACIP age cut-offs for HPV vaccination, or account for a specific individual's situation such as how sexually active they are.

In addition, ChatGPT provided reassurances for people with an egg allergy and influenza vaccination, and addressed misconceptions around mRNA vaccination and permanent alterations in DNA with high accuracy. However, it did not offer the non-mRNA vaccine options for COVID-19, but did encourage further discussions with healthcare professionals.

ChatGPT also appropriately acknowledged the complexity of religious issues around vaccination and directed individuals to have further discussions with religious leaders. Importantly, however, the researchers found that without specific details of the religious concern and the specific vaccine, ChatGPT's advice was generic and it did not provide a more detailed risk-benefit discussion.

"Overall, ChatGPT's responses to vaccine hesitancy were accurate and may help individuals who have vaccine-related misconceptions", says Dr Koh, who is also an infectious diseases physician at the National University Hospital in Singapore. "Our results demonstrate the potential power of AI models to assist in public health campaigns and aid health professionals in reducing vaccine hesitancy."

STI responses generally accurate and concise

The researchers also found that overall, ChatGPT's responses on STIs were mostly accurate and concise.

For example, when asked about how to prevent STIs, the chatbot recommended safe sex practices HPV vaccinations as well as abstinence, but it failed to provide guidance on other key elements such as HIV pre-exposure prophylaxis.

In addition, the AI chatbot was able to provide general reassurance about STI symptoms, such as noting that other possibilities exist, and recommended going for testing. It also consistently communicated the importance of partner testing and follow-up testing.

However, when asked about chlamydia treatment, ChatGPT suggested either azithromycin or doxycycline, although the CDC favors doxycycline as the first-line treatment. It also failed to highlight the importance of testing for other STIs.

"ChatGPT provided good general advice about STIs, but it lacked specificity and could not tailor its advice to individual's risk of acquiring STIs", says Dr Koh. "The goal of this project is to empower the general public. The hope is that individuals can educate themselves with ChatGPT by making accurate advice more accessible and increase vaccine uptake and protection from STIs."

He continues "We believe that ChatGPT should be used in conjunction with, or in addition to, a physician consultation – the human response is still needed to contextualize the advice that is given to a specific individual's situation and for it to make the most sense and be the most helpful for the patient."

Sources:
  • ESCMID Global Congress
  • European Society of Clinical Microbiology and Infectious Diseases


Source: http://www.news-medical.net/news/20240410/ChatGPT-could-be-an-effective-tool-to-help-reduce-vaccine-hesitancy.aspx

Inline Feedbacks
View all comments
guest